1. Home
  2. MLTX vs MEOH Comparison

MLTX vs MEOH Comparison

Compare MLTX & MEOH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MLTX
  • MEOH
  • Stock Information
  • Founded
  • MLTX 2021
  • MEOH 1968
  • Country
  • MLTX Switzerland
  • MEOH Canada
  • Employees
  • MLTX N/A
  • MEOH N/A
  • Industry
  • MLTX Biotechnology: Pharmaceutical Preparations
  • MEOH Major Chemicals
  • Sector
  • MLTX Health Care
  • MEOH Industrials
  • Exchange
  • MLTX Nasdaq
  • MEOH Nasdaq
  • Market Cap
  • MLTX 2.3B
  • MEOH 2.5B
  • IPO Year
  • MLTX N/A
  • MEOH N/A
  • Fundamental
  • Price
  • MLTX $38.33
  • MEOH $27.02
  • Analyst Decision
  • MLTX Strong Buy
  • MEOH Buy
  • Analyst Count
  • MLTX 8
  • MEOH 8
  • Target Price
  • MLTX $80.50
  • MEOH $49.50
  • AVG Volume (30 Days)
  • MLTX 489.2K
  • MEOH 698.0K
  • Earning Date
  • MLTX 05-06-2025
  • MEOH 04-28-2025
  • Dividend Yield
  • MLTX N/A
  • MEOH 2.74%
  • EPS Growth
  • MLTX N/A
  • MEOH N/A
  • EPS
  • MLTX N/A
  • MEOH 2.39
  • Revenue
  • MLTX N/A
  • MEOH $3,719,829,000.00
  • Revenue This Year
  • MLTX $103.42
  • MEOH $17.69
  • Revenue Next Year
  • MLTX N/A
  • MEOH $5.92
  • P/E Ratio
  • MLTX N/A
  • MEOH $11.10
  • Revenue Growth
  • MLTX N/A
  • MEOH N/A
  • 52 Week Low
  • MLTX $31.42
  • MEOH $25.46
  • 52 Week High
  • MLTX $58.26
  • MEOH $56.43
  • Technical
  • Relative Strength Index (RSI)
  • MLTX 51.82
  • MEOH 30.64
  • Support Level
  • MLTX $31.90
  • MEOH $26.47
  • Resistance Level
  • MLTX $37.73
  • MEOH $28.01
  • Average True Range (ATR)
  • MLTX 2.99
  • MEOH 2.00
  • MACD
  • MLTX 0.29
  • MEOH -0.04
  • Stochastic Oscillator
  • MLTX 74.53
  • MEOH 15.84

About MLTX MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is a clinical-stage biotechnology company advancing therapies to address unmet needs in inflammatory skin and joint diseases. The company is focused on the development of SLK, a novel tri-specific IL-17A and IL-17F inhibiting Nanobody that has the potential, based on response levels seen in clinical trials, to drive disease modification in dermatology and rheumatology patients.

About MEOH Methanex Corporation

Methanex Corp manufactures and sells methanol. Its customers use methanol as a feedstock to produce end-products including adhesives, foams, solvents, and windshield washer fluids. The firm also sells its products to the oil refining industry, where the methanol is blended with gasoline to produce a high-octane fuel or blended as a component of biodiesel. It distributes its products through a global supply chain that includes the operation of port terminals, tankers, barges, rail cars, trucks, and pipelines. The company generates the majority of its revenue from Europe.

Share on Social Networks: